Dr. Andrén received his MD at Uppsala University, Sweden. He is Professor of Urology and head of the department of Urology at Örebro University Hospital. He is working clinically as an urologist with mainly prostate cancer patients. Dr Andrén has worked with prostate cancer research since 2000 and made his PhD on prognostic and predictive markers in prostate cancer. He is involved in prostate cancer research that reaches from clinical trials to molecular biology in prostate cancer with an interest in prognostic and predictive markers as well as biology around treatment response and the role of infection and inflammation in prostate cancer development.